Quality of Life in Patients With Postoperative Atrial Fibrillation After Cardiac Surgery
Prospective Observational Study on Quality of Life With Postoperative Atrial Fibrillation
1 other identifier
observational
260
1 country
1
Brief Summary
Prospective observational study on quality of life with postoperative atrial fibrillation after cardiac surgery using SF-36 and qualitative questions
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2025
CompletedFirst Submitted
Initial submission to the registry
September 8, 2025
CompletedFirst Posted
Study publicly available on registry
September 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
June 29, 2026
June 1, 2026
1.5 years
September 8, 2025
June 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
SF-36 scores
compare development and absolut SF-36 scores
before, one month and three months postop
Secondary Outcomes (2)
Qualitative questions
before, one month and three months postop
TSQM-9 scores
one month and three months postop
Study Arms (1)
Target group
Adult patients undergoing cardiac surgery with cardiopulmonary bypass
Interventions
Eligibility Criteria
Adult patients undergoing cardiac surgery with cardiopulmonary bypass
You may qualify if:
- All genders
- Ages 18-99 years old
- Scheduled to undergo cardiac surgery
- Able to answer survey questions
You may not qualify if:
- Persistent / permanent atrial fibrillation
- Atrial fibrillation at presentation for surgery
- Emergent operations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mass General Brigham
Boston, Massachusetts, 02115, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jakob Wollborn, MD, MPH
Brigham and Women's Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 8, 2025
First Posted
September 15, 2025
Study Start
July 15, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
July 1, 2027
Last Updated
June 29, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share